Fear of Cancer Recurrence Inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence
Despite the fact that the fear of cancer recurrence is to varying degrees almost universal in cancer survivors, there is a lack of validated multidimensional instruments to evaluate this issue specifically.
The goal of this study was to develop and empirically validate a multidimensional self-report scale for assessing the fear of cancer recurrence, the Fear of Cancer Recurrence Inventory (FCRI).
A provincial medical databank was used to randomly select a pool of 1,704 French-Canadian patients who had been treated for breast, prostate, lung, and colorectal cancer within the past 10 years. Of these, 300 patients were asked to complete the FCRI on two occasions.
The factorial analysis conducted on the final 42-item scale revealed a seven-component solution (64% of the variance) including the following factors: triggers, severity, psychological distress, coping strategies, functioning impairments, insight, and reassurance. The results also supported the internal consistency (α = 0.95) and the temporal stability (r = 0.89) of the FCRI, as well as its construct validity with other self-report scales assessing fear of cancer recurrence (r = 0.68 to 0.77) or related constructs such as psychological distress (r = 0.43 to 0.77) and quality of life (r = −0.20 to −0.36).
This study suggests that the French-Canadian version of the FCRI is a reliable and valid instrument for evaluating the multidimensional aspects of the fear of cancer recurrence.
KeywordsFear of cancer recurrence Anxiety Cancer Questionnaire Validation
- 1.Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes dJCJM, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRefGoogle Scholar
- 2.American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. American Psychiatric Association, Washington, DCGoogle Scholar
- 3.Anastasi A, Urbina S (1997) Psychological testing. Prentice-Hall, Upper Saddle River, NJGoogle Scholar
- 6.Brunet A (1997) Épidémiologie des événements traumatiques et effets des expositions multiples chez des chauffeurs de bus urbains [Epidemiology of traumatic events and impact of multiple exposure among urban bus drivers]. Thesis, Département de psychologie, Université de Montréal, MontréalGoogle Scholar
- 8.Clark DA (2005) Intrusive thoughts in clinical disorders: theory, research and treatment. Guilford, New YorkGoogle Scholar
- 9.Cronbach LJ (1984) Essentials of psychological testing. Harper and Row, New-YorkGoogle Scholar
- 15.Greenberg DB, Kornblith AB, Herndon JE, Zuckerman E, Schiffer CA, Weiss RB, Mayer RJ, Wolchok SM, Holland JC (1997) Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971–1988: predictors for later psychologic distress. Cancer 80:1936–1944PubMedCrossRefGoogle Scholar
- 20.Humphris GM, Rogers S, McNally D, Lee-Jones C, Brown J, Vaughan D (2003) Fear of recurrence and possible cases of anxiety and depression in orofacial cancer patients. Int J Oral Maxillofac Sur 32:486–491Google Scholar
- 31.National Cancer Institute of Canada (2006) Canadian cancer statistics 2006. National Cancer Institute of Canada, TorontoGoogle Scholar
- 34.Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK (2007) SEER cancer statistics review, 1975–2004. National Cancer Institute, Bethesda, MDGoogle Scholar
- 37.SPSS (1999) Statistical package for the social sciences. SPSS, Chicago, ILGoogle Scholar
- 40.Tabachnik BG, Fidell LS (2001) Using multivariate statistics. Harper Collins, New YorkGoogle Scholar